<DOC>
	<DOCNO>NCT00319007</DOCNO>
	<brief_summary>The purpose study determine whether sulindac VSL # 3 - inulin , either combine alone , effective treat prevent adenoma development ileal anal pouch patient familial adenomatous polyposis .</brief_summary>
	<brief_title>Influence Sulindac Probiotics Development Pouch Adenomas Patients With Familial Adenomatous Polyposis</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Sulindac</mesh_term>
	<criteria>Clinically genetically prove familial adenomatous polyposis Restorative proctocolectomy ileal pouch anal anastomosis Chronic acute renal hepatic disease History oesophageal , gastric duodenal ulcer Known hypersensitivity sulindac Daily use last three month : Aspirin NonSteroidal AntiInflammatory Agents Probiotics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>